Targeting Research
In order to generate new ideas to better treat or cure IBD, Crohn’s and Colitis Canada supports a number of targeted research programs (Government Partnerships, Industry Partnerships, GEM Project). Our continued investment in these programs ensures a diversified research portfolio and invests strategically in programs that are key issues for our patient community.
Government Partnerships
In collaboration with the Canadian Institutes of Health Research (CIHR) and Genome Canada, Crohn’s and Colitis Canada has leveraged its funds to support cutting-edge team grants related to critical IBD issues.
Researcher Dr. Laura Sly Institution University of
Dr. Ken Croitoru Mount Sinai Hospital
Project Crohn’s disease variants predispose to British Columbia commensal-driven autoinflammation
Influences of host genome on the HUMAN gut microbiome: studies in
a healthy cohort carrying Crohn’s disease risk alleles
Dr. John Rioux Université de Montréal
CIHR team in integrative biology of inflammatory disease: IL23R as a
confirmed immune disease pathway: a model for translating genetics discoveries into better diagnosis and treatment of common disease
Dr. Alain Stintzi
University of Ottawa
Dr. John Rioux Université de Montréal The microbiota at the intestinal
mucosa-immune interface: a gateway for personalized health
IBD Genomic Medicine Consortium (iGenoMed): translating genetic
discoveries into a personalized approach to treating the inflammatory bowel diseases
Year 1 of 4 $ 7,500
Year 1 of 4 $ 25,000
Year 5 of 5 $ 16,667
Our Contribution
Year 1 of 1 $ 20,000
Year 4 of 5 $ 25,000
RESEARCH REPORT 2014 | 10
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32